![Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis - The Lancet Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis - The Lancet](https://www.thelancet.com/cms/attachment/f58a1e92-6f18-456b-b74a-0a87e1f7ca10/gr1_lrg.gif)
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis - The Lancet
![Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials - The Lancet Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials - The Lancet](https://www.thelancet.com/cms/attachment/34d0316c-933b-42e5-a2ac-b4ab008f2af4/gr1.gif)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials - The Lancet
![Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S259005952200173X-gr1.jpg)
Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect
![Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018 | Scientific Reports Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018 | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-93179-8/MediaObjects/41598_2021_93179_Fig5_HTML.png)
Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018 | Scientific Reports
![Frontiers | Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease Frontiers | Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease](https://www.frontiersin.org/files/Articles/1004473/fcvm-09-1004473-HTML/image_m/fcvm-09-1004473-g001.jpg)
Frontiers | Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease
![Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S259005952200173X-fx1.jpg)
Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect
![P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | Journal of the American College of Cardiology P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/2a299f30-d123-45a6-b68a-c12d3a79d86d/fx1.jpg)
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | Journal of the American College of Cardiology
![2 The use of aspirin for primary and secondary prevention of CAD [161] | Download Scientific Diagram 2 The use of aspirin for primary and secondary prevention of CAD [161] | Download Scientific Diagram](https://www.researchgate.net/publication/348259767/figure/fig1/AS:977975415681024@1610178917739/The-use-of-aspirin-for-primary-and-secondary-prevention-of-CAD-161.png)
2 The use of aspirin for primary and secondary prevention of CAD [161] | Download Scientific Diagram
![Understanding the New 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease | Cardiologists located in Cypress, Katy, Houston, Sealy and Fulshear, TX | Memorial Katy Cardiology Associates Understanding the New 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease | Cardiologists located in Cypress, Katy, Houston, Sealy and Fulshear, TX | Memorial Katy Cardiology Associates](https://sa1s3optim.patientpop.com/filters:format(webp)/assets/images/provider/photos/2500811.jpg)
Understanding the New 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease | Cardiologists located in Cypress, Katy, Houston, Sealy and Fulshear, TX | Memorial Katy Cardiology Associates
![Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/b8e58181-8c10-4d46-a114-99ddf25bf6ce/atvbaha.122.318020.fig06.jpg)
Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology
![Full article: Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events Full article: Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events](https://www.tandfonline.com/cms/asset/844104e8-d73a-4cf8-8e38-84a0a95d7bab/ierk_a_2020100_f0003_oc.jpg)